Clinical Trials

CNSGastrointestinalGenitourinaryGynecologicSarcoma

Carcinoma, Hepatocellular

NCT05919264 2026-04-09

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Phase 1/2 Recruiting

595 enrolled

Craniopharyngioma, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Adenomatous Polyposis Coli, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Desmoid Tumors

NCT07392866 2026-02-09

A Clinical Study of SH006 Injection in Combination Therapy Versus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma

Phase 2/3 Not yet recruiting

120 enrolled

Carcinoma, Hepatocellular

NCT05171166 2025-12-18

Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.

Phase 2/3 Terminated

18 enrolled

Carcinoma, Hepatocellular

NCT05007106 2025-08-14

KEYVIBE-005

BreastGastrointestinalGenitourinaryGynecologicHead & Neck

613 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

NCT06741020 2025-05-23

HAICI

Phase 1/2 Recruiting

10 enrolled

Phase 2 Active not recruiting

Carcinoma, Hepatocellular

NCT04251715 2025-04-18

mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma

5 enrolled

Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT06041477 2024-08-27

HAIC

Phase 3 Recruiting

540 enrolled

Carcinoma, Hepatocellular

NCT06349044 2024-08-27

A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.

Phase NA Recruiting

120 enrolled

Phase 3 Active not recruiting

Carcinoma, Hepatocellular

NCT03017326 2024-05-13

PHITT

450 enrolled

Carcinoma, Hepatocellular, Hepatoblastoma

NCT06201065 2024-01-11

FOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind Trial

Phase 3 Recruiting

200 enrolled

Carcinoma, Hepatocellular

NCT05099848 2023-08-15

A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma

21 enrolled

Phase 2/3 Not yet recruiting

Carcinoma, Hepatocellular

NCT05976568 2023-08-04

A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma

668 enrolled

Carcinoma, Hepatocellular

NCT03722498 2023-07-11

Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACE

Phase 2 Withdrawn

Carcinoma, Hepatocellular

NCT04962958 2023-06-22

Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery

30 enrolled

Carcinoma, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms

NCT05718492 2023-02-08

A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents

Phase NA Recruiting

100 enrolled

Carcinoma, Hepatocellular

NCT05617430 2022-11-15

Combination Therapy of HAIC, Sintilimab and Bevacizumab for Advanced Hepatocellular Carcinoma

43 enrolled

Carcinoma, Hepatocellular

NCT05517239 2022-08-26

PEACH

32 enrolled

Carcinoma, Hepatocellular

NCT05493332 2022-08-18

HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC

93 enrolled

Carcinoma, Hepatocellular

NCT05231382 2022-05-24

Hepatic Arterial Infusion of Raltetrexed With Oxaliplatin(SALOX) Versus FOLFOX in Advanced Hepatocellular Carcinoma

426 enrolled

Carcinoma, Hepatocellular

NCT04595864 2021-11-05

Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma Beyond Milan/UCSF Criteria Who Underwent Liver Transplantation

Phase 3 Recruiting

40 enrolled

Carcinoma, Hepatocellular

NCT04994236 2021-08-13

Hepatic Artery Infusion Chemotherapy for Unresectable Hepatocelluar Carcinoma Who Failed to Systemic Therapy

49 enrolled

Carcinoma, Hepatocellular

NCT02129322 2021-02-15

Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1

Phase 2 Withdrawn

Carcinoma, Hepatocellular

NCT04521491 2020-08-20

A Trial of Adjuvant Therapy After Hepatocarcinoma Resection Based on Folate Receptor-positive Circulating Tumor Cells

Phase NA Unknown

184 enrolled

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating

NCT02716766 2020-04-10

Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC)

46 enrolled

Carcinoma, Hepatocellular, Neoplasm Metastasis

NCT03578874 2020-04-09

SECOX as Neoadjuvant Therapy in Patients With Locally Advanced HCC

15 enrolled

Carcinoma, Hepatocellular

NCT02774187 2019-12-05

Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC

Phase 3 Completed

247 enrolled

Carcinoma, Hepatocellular

NCT00941655 2019-11-13

Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial

Phase 3 Completed

15 enrolled 18 charts

Carcinoma, Hepatocellular, Stomach Neoplasms

NCT02436044 2019-08-20

HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC

Approved for marketing

Carcinoma, Hepatocellular, Wounds and Injuries

NCT00941967 2019-07-10

Sorafenib With or Without Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Liver Cancer

78 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT02527772 2019-06-04

LD-FOX4/HCC

Phase 2/3 Withdrawn

Carcinoma, Hepatocellular

NCT02534337 2019-06-04

Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma

Phase 2/3 Withdrawn

Carcinoma, Hepatocellular

NCT02585479 2019-06-04

Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma

Phase 2/3 Withdrawn

Carcinoma, Hepatocellular

NCT03812770 2019-04-17

Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCC

150 enrolled

Carcinoma, Hepatocellular

NCT02069041 2018-11-21

A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer

Phase 1 Completed

8 enrolled 16 charts

Carcinoma, Hepatocellular

NCT03468231 2018-03-16

HAIC of FOLFOX vs. HAIC of OXA for Advanced HCC

300 enrolled

Carcinoma, Hepatocellular

NCT02089633 2017-07-28

PACOX

17 enrolled

Carcinoma, Hepatocellular

NCT00483405 2017-07-12

NRR

33 enrolled 14 charts

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00861783 2017-06-23

Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma

Phase 1 Completed

16 enrolled

Carcinoma, Hepatocellular

NCT03192618 2017-06-20

The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

290 enrolled

Carcinoma, Hepatocellular

NCT03192644 2017-06-20

The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

162 enrolled

Carcinoma, Hepatocellular

NCT01229111 2017-03-29

Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers

Phase 2 Terminated

14 enrolled 11 charts

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular

NCT01313377 2017-01-25

Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery

Phase 3 Completed

190 enrolled

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms

NCT02987699 2016-12-28

Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil

54 enrolled

Carcinoma, Hepatocellular

NCT02403544 2016-01-05

Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma

Phase 1 Unknown

30 enrolled

Carcinoma, Hepatocellular

NCT02426450 2015-04-27

RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC

28 enrolled

Carcinoma, Hepatocellular

NCT00142467 2014-03-18

Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma

33 enrolled

Carcinoma, Hepatocellular

NCT00003427 2013-06-26

Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer

Phase 1 Completed

36 enrolled

Anus Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT00052364 2013-06-18

Oxaliplatin in Treating Patients With Liver Cancer

32 enrolled